Long-circulating, pH-sensitive liposomes versus long-circulating, non-pH-sensitive liposomes as a delivery system for tumor identification

Journal of Biomedical Nanotechnology

Volumn 9, Issue 9, 2013, Pages 1636-1643

  De Barros, André Luís Branco ^a   Mota, Luciene Das Graças ^a   Soares, Daniel Crístian Ferreira ^a   De Souza, Cristina Maria ^a   Cassali, Geovanni Dantas ^a   Oliveira, Mônica Cristina ^a   Cardoso, Valbert Nascimento ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bombesin; Liposomes; PH Sensitivity; Radiopharmaceutical; Radiotracer; Scintigraphic imaging; Tumor

Indexed keywords

BOMBESIN; PH-SENSITIVITY; RADIOPHARMACEUTICAL; RADIOTRACER; SCINTIGRAPHIC IMAGING;

BAYESIAN NETWORKS; DRUG DELIVERY; MUSCLE; PEPTIDES; PH SENSORS; PLASMA STABILITY; RADIOACTIVE TRACERS; TUMORS;

LIPOSOMES;

BOMBESIN DERIVATIVE; BOMBESIN[7-14] TC 99M; LIPOSOME; NANOCARRIER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; EHRLICH ASCITES TUMOR; ELECTROPHORETIC MOBILITY; HISTOPATHOLOGY; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PLASMA CLEARANCE; RADIOACTIVITY; TUMOR DIAGNOSIS; TUMOR SCINTISCANNING; ZETA POTENTIAL;

ANIMALS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MALE; MATERIALS TESTING; METABOLIC CLEARANCE RATE; MICE; NANOCAPSULES; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84883311011     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1649     Document Type: Article

References (30)

1. A. Anastasi, V. Erspamer, and M. Bucci, Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia. 27, 166 (1971).
2. M. Langer and A. G. Beck-Sickinger, Peptides as carrier for tumor diagnosis and treatment. Curr. Med. Chem.-Anti-Cancer Agents. 1, 71 (2010).
3. J. Schuhmacher, H. Zhang, J. Doll, H. R. Macke, R. Matys, H. Hauser, M. Henze, U. Haberkorn, and M. Eisenhut, GRP receptortargeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog. J. Nucl. Med. 46, 691 (2005).
4. F. Scopinaro, A. D. de Vincentis, and A. D. Varvarigou, Use of radiolabeled bombesin in humans. J. Clin. Oncol. 23, 3170 (2005).
5. A. L. B. de Barros, L. G. Mota, C. A. Ferreira, M. C. Oliveira, A. M. Góes, and V. N. Cardoso, Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification. Bioorg. Med. Chem. Lett. 20, 6182 (2010)
6. M. U. Uhumwangho and R. S. Okor, Current trends in the production and biomedical applications of liposomes: a review. J. Med. Biomed. Res. 4, 9 (2005).
7. J. V. den Bossche, W. T. Al-Jamal, A. Yilmazer, E. Bizzarri, B. Tian, and K. Kostarelos, Intracellular trafficking and gene expression of pH-sensitive artificially enveloped adenoviruses in vitro and in vivo. Biomaterials. 32, 3085 (2011).
8. V. P. Torchilin, Recent advances with liposomes as pharmaceutical carries. Nat. Rev. Drug Discov. 4, 145 (2005).
9. M. Ferrari, Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer. 5, 161 (2005).
10. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Sin, Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310 (2008).
11. M. C. de Oliveira, E. Fattal, P. Couvreur, P. Lesieur, C. Bourgaux, M. Ollivon, and C. Dubernet, pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. Biochim. Biophys. Acta. 1372, 301 (1998).
12. C. S. Giuberti, E. C. O. Reis, T. G. R. Rocha, E. A. Leite, R. G. Lacerda, G. A. Ramaldes, and M. C. de Oliveira, Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin. J. Liposome Res. 21, 60 (2011).
13. A. L. B. de Barros, L. G. Mota, D. C. F. Soares, M. M. A. Coelho, M. C. Oliveira, and V. N. Cardoso, Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification. Bioorg. Med. Chem. Lett. 21, 7373 (2011).
14. A. L. B. de Barros, A. Tsourkas, B. Saboury, V. N. Cardoso, and A. Alavi, Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. Eur. J. Nucl. Med. Mol. Imaging Res. 39, 1 (2012).
15. G. R. Bartlett, Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466 (1959).
16. A. L. B. de Barros, L. G. Mota, C. A. Ferreira, and V. N. Cardoso, Kit formulation for 99mTc-labeling of HYNIC-Ala-Bombesin(7-14). Appl. Rad. Isot. 70, 2440 (2012).
17. K. Maeda, Y. S. Chung, S. Takatsuka, Y. Ogawa, N. Onoda, T. Sawada, Y. Kato, A. Nitta, Y. Arimoto, and Y. Kondo, Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br. J. Cancer. 72, 319 (1995).
18. M. C. Woodle, L. R. Collins, E. Sponsler, N. Kossovisky, D. Papahadjopoulos, and F. J. Martin, Sterically stabilized liposomes: reduction in electrophorectic mobility but not electrostatic surface potential. Biophys. J. 61, 902 (1992).
19. D. F. Driscoll, Lipid injectable emulsion: Pharmacopeital and safety issues. Pharm. Res. 23, 1959 (2003).
20. V. P. Torchilin, Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 9, 128 (2007).
21. D. C. Litzinger, A. M. J. Buiting, N. van Rooijen, and L. Huang, Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta. 1190, 99 (1994).
22. D. E. Owens and N. A. Peppas, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93 (2006).
23. M. A. Pereira, V. C. F. Mosqueira, J. M. C. Vilela, M. S. Andrade, G. A. Ramaldes, and V. N. Cardoso, PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: Release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy. Eur. J. Pharm. Sci. 33, 42 (2008).
24. J. J. Virrey, D. Dong, C. Stiles, J. B. Patterson, L. Pen, M. Ni, A. H. Chonthal, T. C. Chen, F. M. Hofman, and A. S. Lee, Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol. Cancer Res. 6, 1268 (2008).
25. H. Y. Jun, H. H. Yin, S. H. Kim, S. H. Park, H. S. Kim, and K. H. Yoon, Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model. Korean J. Radiol. 11, 449 (2010).
26. T. C. Chua, P. Yao, J. Akther, and D. L. Morris, Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy. Pathol. Oncol. Res. 16, 217 (2010).
27. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D. A. Berk, V. P. Torchilin, and R. Jain, Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res. 55, 3752 (1995).
28. L. L. Munn, Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov. Today. 8, 396 (2003).
29. W. T. Phillips, Delivery of gamma-imaging agents by liposomes. Adv. Drug Deliv. Rev. 37, 13 (1999).
30. A. D. Carvalho-Júnior, L. G. Mota, E. A. Numan, A. J. A. Wainstein, A. P. D. L. Wainstein, A. S. Leal, V. N. Cardoso, and M. C. Oliveira, Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Science 80, 659 (2007).